603235 天新藥業
按盤價 
25.140 -0.060 (-0.238%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.443 | 12.412 | 14.719 | 11.479 | 20.853 |
| 總資產報酬率 ROA (%) | 5.056 | 10.033 | 12.180 | 9.741 | 16.302 |
| 投入資產回報率 ROIC (%) | 5.886 | 11.682 | 14.215 | 11.245 | 19.443 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.070 | 42.312 | 42.011 | 38.272 | 37.225 |
| 營業利潤率 (%) | 29.064 | 30.077 | 35.061 | 29.874 | 31.486 |
| 息稅前利潤/營業總收入 (%) | 31.052 | 28.960 | 29.961 | 24.588 | 27.560 |
| 淨利潤/營業總收入 (%) | 24.387 | 25.227 | 29.486 | 25.285 | 26.992 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.974 | 95.164 | 95.151 | 92.313 | 91.246 |
| 價值變動淨收益/利潤總額(%) | 1.433 | 1.267 | 0.996 | 0.367 | 1.511 |
| 營業外收支淨額/利潤總額(%) | -0.032 | -0.127 | -0.335 | 0.522 | 0.009 | 償債能力分析 |
| 流動比率 (X) | 3.558 | 4.378 | 5.287 | 6.766 | 10.175 |
| 速動比率 (X) | 2.752 | 3.482 | 4.131 | 5.728 | 8.663 |
| 資產負債率 (%) | 22.433 | 20.570 | 17.622 | 16.841 | 13.290 |
| 帶息債務/全部投入資本 (%) | 3.498 | 1.600 | -3.915 | -5.832 | -6.832 |
| 股東權益/帶息債務 (%) | 2,591.825 | 5,754.929 | -2,462.095 | -1,659.567 | -1,452.416 |
| 股東權益/負債合計 (%) | 345.776 | 386.153 | 467.476 | 493.804 | 652.428 |
| 利息保障倍數 (X) | 15.547 | -26.848 | -6.012 | -4.518 | -7.013 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 41.188 | 44.729 | 42.097 | 46.593 | 46.227 |
| 存貨周轉天數 (天) | 146.352 | 154.228 | 150.130 | 147.134 | 109.004 |
| 備註： | 即時報價更新時間為 29/09/2026 15:15 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
